Company Legal Name
Latest Valuation
Founded Year
Headquarters
OpenEvidence Inc. develops AI-powered clinical decision support software that serves as an intelligent copilot for healthcare professionals at the point of care. Founded in 2021 and headquartered in Cambridge, Massachusetts, the company leverages artificial intelligence to assist doctors in making critical medical decisions by providing real-time, evidence-based recommendations. The platform addresses the growing need for enhanced clinical decision-making tools in an increasingly complex healthcare environment. With a current valuation of $3.5 billion, OpenEvidence has established itself as a significant player in the healthcare AI sector. The company continues to focus on expanding its clinical applications and improving diagnostic accuracy for medical professionals.
Availability of information and platform features may vary by region and applicable requirements.
Eligibility and access may depend on user location, verification status, and applicable legal or regulatory requirements.
Additional platform details may be available after account creation, where applicable.
Identity, compliance, and other review steps may be required before access to certain materials or features.
Platform details, if applicable, should be reviewed in account materials before making any decision.
Any economic terms, if applicable, should be reviewed carefully in the relevant materials.
Private market interests may be illiquid, restricted, or difficult to transfer. Users should not assume that any secondary market will be available.
Valuations may reflect past financing rounds or other available information and may not represent a price at which any person can transact.
Company and sector risks may vary by business model, technology development, competition, regulation, and market conditions.
Operational, documentation, custody, or verification processes may involve limitations, delays, or dependencies.
Regulatory, tax, and legal requirements may change and may affect information availability, platform features, or user eligibility.
